Speaker(s): 

Liping Li, MD, Resident, Geisinger - has nothing to disclose.

Sahrish Shah, MD, Resident, Geisinger - has nothing to disclose.

Moderator(s): 

Zachary Hoffer, MD, Staff Physician, Geisinger - has nothing to disclose. 

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• Define morphologic and genomic spectrum of NF-mutated melanocytic neoplasms.
• Evaluate NF-mutated DMs vs. non-NF DMs and NF-mutated desmoplastic nevi.
• Describe platelet refractoriness and its causes (immune vs. non immune)
• Explain the diagnostic approach and management algorithm

Disclosure of Relevant Financial Relationships without Commercial Interests:

The Planning Committee consisting of Zachary Hoffer, MD PhD have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure:  None.

This presentation/content is HIPAA compliant. 

Commercial Support for this Session:  None.